Hon. Dr. Walter Copan

Dr. Walter Copan is cofounder of the Renewing American Innovation Project at the Center for Strategic and International Studies. Currently, he serves as vice president for research and technology transfer at the Colorado School of Mines in Golden, Colorado. He previously served as under secretary of commerce for standards and technology and 16th director of the National Institute of Standards and Technology (NIST), a position to which he was confirmed unanimously by the Senate. He served as the U.S. principal presidential adviser on standards policy and technology matters and provided high-level oversight and strategic leadership for NIST, a world-leading science and technology institute. Under his widely acclaimed leadership, he spearheaded streamlining and modernization of foundational policies and practices for innovation and technology transfer arising from federally funded research to benefit the economy and society. Dr. Copan is a distinguished leader with wide-ranging experience spanning large company, entrepreneurial tech start-up, U.S. government, nonprofit, and other public sector settings. For the U.S. government, he also served with two of the Department of Energy national laboratories: the National Renewable Energy Laboratory and Brookhaven National Laboratory. He is a sought-after speaker and thought leader on matters of science and technology, strategy, entrepreneurship, technology commercialization, intellectual property, and innovation. Dr. Copan began his career in research and development and business leadership at the Lubrizol Corporation. He earned undergraduate degrees and his PhD in physical chemistry from Case Western Reserve University and holds a certificate in advanced business administration studies at Harvard Business School. He was named 2020 laboratory director of the year by the U.S. Federal Laboratory Consortium. The Association of University Technology Managers (AUTM) recognized Dr. Copan with its 2021 Bayh-Dole Award for contributions to innovation and technology transfer.

Securing the Future of the U.S. Biopharmaceutical Industry: The Most-Favored-Nation Paradox

By Sujai Shivakumar and Anne Pritchett The Trump administration is pursuing lowering prescription drug costs primarily to end what it describes as “global freeloading” and to ensure U.S. patients pay prices comparable to those in other developed nations. The administration argues that while the United States represents less than 5 percent
Read More

Universities, Patents, and the Future of U.S. Competitiveness

By Shruti Sharma and Chris Borges Universities are among the most powerful engines of U.S. innovation, transforming federal research investments into scientific discoveries that underpin economic growth, technological leadership, and national security. Current law, via the Bayh-Dole Act, allows universities to patent inventions and license them to private companies, with royalties
Read More

How Counterfeit Drugs Threaten U.S. Health and Innovation

By Anne Pritchett According to the Department of Homeland Security, counterfeit drugs “threaten national security and public safety directly when introduced into government and critical infrastructure supply chains, and indirectly if used to generate revenue for transnational criminal organizations.” Furthermore, counterfeit drugs harm pharmaceutical innovation by eroding profitability and investor
Read More